SCHEMBL5166707

SCHEMBL5166707

CC1(C)NC(=O)N(CCNc2ncc(-c3cccc4[nH]ccc34)c(-c3ccc(Cl)s3)n2)C1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 1/20 0.36
KDR P35968 1/20 0.36
HTT P42858 1/20 0.33
EED O75530 1/20 0.33
ALDH1A1 P00352 2/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33
GAA P10253 1/20 0.33
PDCD1 Q15116 1/20 0.32
CD274 Q9NZQ7 1/20 0.32
CCNC P24863 1/20 0.32
CDK8 P49336 1/20 0.32
HAVCR2 Q8TDQ0 1/20 0.31
BRD4 O60885 1/20 0.31
CDK9 P50750 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
CDK7 P50613 1/20 0.31
CCNH P51946 1/20 0.31
PGK1 P00558 1/20 0.31
ROCK2 O75116 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2984988 0.88 KDR (0.36) CDK1KDREEDPDCD1CD274
SCHEMBL5149053 0.84 ALDH1A1 (0.41) HTTALDH1A1NPC1LMNAGAA
Tert-Butyl Formate SCHEMBL27688664 0.83 CDK1 (0.33) CDK1KDRCCNCCDK8
SCHEMBL28770296 0.82 KDR (0.37) CDK1KDREEDHAVCR2CDK7
SCHEMBL5147429 0.81 ADORA1 (0.37) HTTALDH1A1NPC1LMNAGAA
SCHEMBL5147378 0.81 ADORA1 (0.40) HTTALDH1A1NPC1LMNAGAA
SCHEMBL5146079 0.80 ALDH1A1 (0.38) HTTALDH1A1NPC1LMNAGAA
SCHEMBL5145833 0.78 ALDH1A1 (0.43) HTTALDH1A1NPC1LMNAGAA
SCHEMBL5147468 0.76 SMN1; SMN2 (0.40) HTTALDH1A1NPC1LMNAGAA
SCHEMBL2986424 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831207-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-09-12 EP disclosed
WO-2006066172-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE AMGEN, INC. (US) 2006-06-22 WO disclosed